COVID 19: Evaluate of Liver and Renal Function Tests in Iraqi Patients

Abstract

The clinical features of COVID-19 are varied, ranging from asymptomatic state to acute respiratory distress syndrome and multi organ dysfunction. We aim to evaluate renal and liver functions of patients with COVID 19. Laboratory results were obtained from 107 patients with laboratory-confirmed COVID-19 who were admitted to the only Al-Furat General Hospital in Baghdad, Iraq from March 3 to June 9, 2020 and followed up until recovery. Normal levels of renal functions were presented. Meanwhile elevated levels of alanine aminotransferase (ALT) was observed in 10% and of aspartate aminotransferase (AST) was observed in 40% of patients with COVID 19,yet on comparison of the results at entering with at recovery it was observed significant differences (p<0.01) of all patients. From these findings we conclude that the virus might be responsible for systemic inflammation.

The effect of Favipiravir on liver enzyme among patients with mild to moderate COVID-19 infection: A prospective cohort study

“…second or third week. 8 Various diagnosis methods, such as serological, molecular, and radiological, can aid health centers in detecting SARS-CoV-2. Radiological and serological techniques are the best among the others, and the radiological method is the most preferred one as it could diagnose the infection quickly and accurately with fewer false-negatives.…”